Tamoxifen
What's New
Last Posted: Feb 11, 2024
- Cost-Effectiveness of Gene-Specific Prevention Strategies for Ovarian and Breast Cancer.
Xia Wei et al. JAMA Netw Open 2024 7(2) e2355324 - Patient-Level Exposure to Actionable Pharmacogenomic Medications in a Nationally Representative Insurance Claims Database.
Monica L Bianchini et al. J Pers Med 2023 13(11) - An updated examination of the perception of barriers for pharmacogenomics implementation and the usefulness of drug/gene pairs in Latin America and the Caribbean.
Aimeé Salas-Hernández et al. Front Pharmacol 2023 141175737 - The Rochester Modified Magee Algorithm (RoMMa): An Outcomes Based Strategy for Clinical Risk-Assessment and Risk-Stratification in ER Positive, HER2 Negative Breast Cancer Patients Being Considered for Oncotype DX Testing.
Bradley M Turner et al. Cancers 2023 15(3) - Glutamine synthetase regulates the immune microenvironment and cancer development through the inflammatory pathway.
Xuan Do Thi Minh et al. International journal of medical sciences 2023 20(1) 35-49 - Optimal breast cancer risk reduction policies tailored to personal risk level.
Ergun Mehmet A et al. Health care management science 2022 - Limiting systemic endocrine overtreatment in postmenopausal breast cancer patients with an ultralow classification of the 70-gene signature.
Opdam M et al. Breast cancer research and treatment 2022 - Comparison of StemPrintER with Oncotype DX Recurrence Score for predicting risk of breast cancer distant recurrence after endocrine therapy.
Pece Salvatore et al. European journal of cancer (Oxford, England : 1990) 2022 16452-61 - Attitude towards hereditary cancer risk management among women with cancer in Taiwan.
Fang Su-Ying et al. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2022 - Association between genetic polymorphisms in cytochrome P450 enzymes and survivals in women with breast cancer receiving adjuvant endocrine therapy: a systematic review and meta-analysis.
Chan Carmen Wing Han et al. Expert reviews in molecular medicine 2022 24e1
More
About PGx PHGKB
PGx PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other materials that address the translation of genomic and other precision health discoveries into improved health care and prevention related to medications....more
Content Summary
Common PGx Related Topics
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:Mar 27, 2024
- Content source: